NeutanPharma Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$31.5M
- Investors
-
7
NeutanPharma General Information
Description
Provider of one-stop CDMO services. The company provides one-stop CDMO services for CMC research and production of APIs and preparations, covering formulation process development, quality research, registration and declaration of chemical APIs and preparations, as well as providing customers with compliance, enabling domestic and foreign pharmaceutical companies and biotechnology companies with comprehensive CDMO and OEM services.
Contact Information
Website
www.neutanpharma.comCorporate Office
- Building 26, Lane 555, Huanqiao Road
- Kangqiao Town, Pudong New Area
- Shanghai, 201315
- China
Corporate Office
- Building 26, Lane 555, Huanqiao Road
- Kangqiao Town, Pudong New Area
- Shanghai, 201315
- China
NeutanPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 29-Mar-2022 | $31.5M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 03-Jan-2022 | Completed | Generating Revenue |
NeutanPharma Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Addor Capital | Growth/Expansion | Minority | ||
| Grand Yangtze Capital | Venture Capital | Minority | ||
| Highlight Capital | Venture Capital | Minority | ||
| JZ Fund | Growth/Expansion | Minority | ||
| Kangcheng Capital | Growth/Expansion | Minority |
NeutanPharma FAQs
-
When was NeutanPharma founded?
NeutanPharma was founded in 2019.
-
Where is NeutanPharma headquartered?
NeutanPharma is headquartered in Shanghai, China.
-
What industry is NeutanPharma in?
NeutanPharma’s primary industry is Drug Discovery.
-
Is NeutanPharma a private or public company?
NeutanPharma is a Private company.
-
What is NeutanPharma’s current revenue?
The current revenue for NeutanPharma is .
-
How much funding has NeutanPharma raised over time?
NeutanPharma has raised $31.5M.
-
Who are NeutanPharma’s investors?
Addor Capital, Grand Yangtze Capital, Highlight Capital, JZ Fund, and Kangcheng Capital are 5 of 7 investors who have invested in NeutanPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process